Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05159466 · ClinicalTrials.gov registry record

Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors

A clinical trial of End Stage Renal Disease and Human Immunodeficiency Virus, sponsored by Tulane University.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT05159466 is a study of End Stage Renal Disease and Human Immunodeficiency Virus that is actively recruiting participants, run by Tulane University. The registered enrollment target is 30 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05159466, a study of End Stage Renal Disease and Human Immunodeficiency Virus, is actively recruiting participants, sponsored by Tulane University.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), published Final Human Immunodeficiency Virus (HIV) Organ Policy Equity (HOPE) Act Safeguards and Research Criteria for Transplantation of Organs Infected With HIV. All such transplants must occur under an institutional review board (IRB) approved research protocol that is compliant with federal regulations governing human subjects research. This is an investigator-initiated, observational prospective study of solid organ transplantation utilizing HIV-positive donors in HIV positive recipients. Stable HIV-infected adults in need of a solid organ transplant (kidney) who meet standard and study specified HIV criteria for organ transplantation will be offered enrollment in the study. Deceased donors (kidney) and living donors (kidney) will be utilized in this protocol. The goal of this research is to increase knowledge about the safety, efficacy, and effectiveness of solid organ transplantation (SOT) utilizing HIV-positive donors in HIV-positive recipients.

Conditions Studied

End Stage Renal Disease Human Immunodeficiency Virus

Interventions

  • PROCEDURE Kidney transplant

Study Locations (1)

Louisiana

  • East Jefferson General Hospital - Metairie

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-11-15
Est. Completion 2026-11

Sponsor

Tulane University

73 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05159466

The ClinicalTrials.gov registry entry for NCT05159466 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (96% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Kidney transplant is the first listed.

NCT05159466 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT05159466 about?

NCT05159466 is a clinical study titled "Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors". The U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), published Final Human Immunodeficiency Virus (HIV) Organ Policy Equity (HOPE) Act Safeguards and Research Criteria for Transplantation of Organs Infected With HIV. All such transplants must occur...

What is the current status of trial NCT05159466?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2021-11-15. Estimated completion is 2026-11.

What conditions does trial NCT05159466 study?

This clinical trial studies the following conditions: End Stage Renal Disease, Human Immunodeficiency Virus.

What interventions are being tested in trial NCT05159466?

The interventions under investigation include: Kidney transplant (PROCEDURE).

Who is sponsoring clinical trial NCT05159466?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05159466 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Human Immunodeficiency Virus

All registered trials for this condition

Louisiana

All trials with a study site in Louisiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.